Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have mapped how herpes simplex virus 1 (HSV-1) spreads through human skin, using lab-grown skin organoids as a model. The work, published in Science Advances, tracks the infection cell by cell and shows that different skin cell types respond to the virus in different ways.
HSV-1 is usually thought of as a cause of cold sores, which typically heal within about two weeks. The virus can also settle in sensory nerve cells in the face and stay dormant there. In rare cases it reaches the central nervous system and causes life-threatening brain inflammation. Researchers are also investigating whether its lifelong persistence in the nervous system could contribute to Alzheimer's disease, though the source material presents that as an open question rather than an established link.
The organoids used in the study were three-dimensional and contained many features of real human skin, including epidermal cells, dermal cells, hair follicles and nerve-like cells. That mattered because flat cell cultures can show how a virus behaves in a single cell type but cannot capture how infection moves between layers. In the organoids, the virus did not hit every cell type at the same pace. Fibroblasts in the dermis carried large amounts of virus early on, while basal keratinocytes and several hair follicle cell types carried lower amounts even when infected cells were nearby. The virus reached hair follicles and sensory neurons only later, which the authors suggest may reflect some intrinsic resistance in those cells.
Using imaging together with spatial transcriptomics, which measures gene activity in individual cells while keeping their position in tissue, the team examined the leading edge of infection. Dermal fibroblasts there switched on IER3, a gene that responds to HSV-1, and basal keratinocytes increased expression of IRF3, a regulator of antiviral defenses. Members of the Tumor Necrosis Factor (TNF) family of signaling molecules also activated in a spatially coordinated way. Wyler notes that TNFs activate the immune system and may be a major factor in how well the body controls the infection.
The authors point to future organoid models that include immune cells and blood vessels as a way to study how the body controls HSV-1 before it reaches nerves, why some cells slow the virus while others support its replication, and how infection and resulting inflammation damage tissue.